24.1K(top 2%)
articles
928.7K(top 1%)
citations
6,502(top 2%)
★★ articles
232(top 2%)
★★★ articles
3(top 13%)
Avg IF
331(top 1%)
H-Index
571(top 1%)
G-Index
2,795
journals

Most Cited Articles of Hospital Clinic of Barcelona in 2018

TitleJournalYearCitations
Hepatocellular carcinomaLancet, The20182.4K
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†Annals of Oncology2018645
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorderBipolar Disorders2018639
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLBlood2018607
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030Journal of Hepatology2018550
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillationEuropace2018461
After asthma: redefining airways diseasesLancet, The2018455
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trialLancet Oncology, The2018451
A randomized trial of normothermic preservation in liver transplantationNature2018450
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosisHepatology2018376
MOG encephalomyelitis: international recommendations on diagnosis and antibody testingJournal of Neuroinflammation2018354
The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version)Ultraschall in Der Medizin2018346
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working GroupMolecular Psychiatry2018340
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trialLancet Oncology, The2018291
Bipolar disordersNature Reviews Disease Primers2018289
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policiesJournal of Hepatology2018266
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetLeukemia2018263
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysisLancet Neurology, The2018254
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosisGut2018232
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summaryEuropace2018227
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusionsEuropean Heart Journal2018225
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseGastroenterology2018220
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trialLancet, The2018219
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled studyLancet Oncology, The2018216
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trialLancet Infectious Diseases, The2018207